| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1991) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | J01FA10 |
| UNII: | J2KLZ20U1M |
Structure
| InChI Key | MQTOSJVFKKJCRP-BICOPXKESA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C38H72N2O12 |
| Molecular Weight | 749.0 |
| AlogP | 1.9 |
| Hydrogen Bond Acceptor | 14.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 180.08 |
| Molecular species | BASE |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 52.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 68 | |
|
Other cytosolic protein
|
- | 300 | - | - | - | |
|
Transporter
Primary active transporter
Oxidoreduction-driven transporters
|
- | - | - | - | 30 | |
|
Unclassified protein
|
- | 300 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Conjunctivitis, Bacterial | 4 | D003234 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 4 | D029424 | ClinicalTrials |
| Infections | 4 | D007239 | ClinicalTrials |
| Bacterial Infections | 4 | D001424 | ClinicalTrials |
| Sinusitis | 4 | D012852 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Asthma | 3 | D001249 | ClinicalTrials |
| Acne Vulgaris | 3 | D000152 | ClinicalTrials |
| Eye Diseases | 3 | D005128 | ClinicalTrials |
| Cough | 3 | D003371 | ClinicalTrials |
| Bronchopulmonary Dysplasia | 3 | D001997 | ClinicalTrials |
| Bronchiectasis | 3 | D001987 | ClinicalTrials |
| Premature Birth | 3 | D047928 | ClinicalTrials |
| Malaria, Falciparum | 3 | D016778 | ClinicalTrials |
| Bronchiolitis Obliterans | 3 | D001989 | ClinicalTrials |
| Syphilis | 3 | D013587 | ClinicalTrials |
| Yaws | 3 | D015001 | ClinicalTrials |
| Gonorrhea | 3 | D006069 | ClinicalTrials |
| Malaria | 3 | D008288 | ClinicalTrials |
| Pregnancy | 3 | D011247 | ClinicalTrials |
| Chlamydia Infections | 3 | D002690 | ClinicalTrials |
| Diarrhea | 3 | D003967 | ClinicalTrials |
| Neonatal Sepsis | 3 | D000071074 | ClinicalTrials |
| Inflammation | 3 | D007249 | ClinicalTrials |
| Malnutrition | 3 | D044342 | ClinicalTrials |
| Blepharitis | 3 | D001762 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| Lung Diseases | 3 | D008171 | ClinicalTrials |
| Coronavirus Infections | 3 | D018352 | ClinicalTrials |
| Mycobacterium avium-intracellulare Infection | 3 | D015270 | ClinicalTrials |
| Pneumonia, Viral | 3 | D011024 | ClinicalTrials |
| Respiratory Insufficiency | 3 | D012131 | ClinicalTrials |
| Digestive System Diseases | 3 | D004066 | ClinicalTrials |
| Bronchial Diseases | 3 | D001982 | ClinicalTrials |
| Fever | 3 | D005334 | ClinicalTrials |
| Vomiting | 3 | D014839 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Abdominal Pain | 3 | D015746 | ClinicalTrials |
| Conjunctivitis, Inclusion | 3 | D003235 | ClinicalTrials |
| Mycobacterium Infections | 3 | D009164 | ClinicalTrials |
| Mycoses | 3 | D009181 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Maxillary Sinusitis | 3 | D015523 | ClinicalTrials |
| Arthritis, Reactive | 3 | D016918 | ClinicalTrials |
| Otitis Media, Suppurative | 3 | D010035 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Obsessive-Compulsive Disorder | 2 | D009771 | ClinicalTrials |
| Respiratory Syncytial Virus Infections | 2 | D018357 | ClinicalTrials |
| Gastrointestinal Hemorrhage | 2 | D006471 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Gastroparesis | 2 | D018589 | ClinicalTrials |
| Bronchiolitis | 2 | D001988 | ClinicalTrials |
| Periodontitis | 2 | D010518 | ClinicalTrials |
| Onchocerciasis | 2 | D009855 | ClinicalTrials |
| Tuberculosis | 2 | D014376 | ClinicalTrials |
| Sarcoidosis | 2 | D012507 | ClinicalTrials |
| Immune System Diseases | 1 | D007154 | ClinicalTrials |
| Toxoplasmosis, Cerebral | 1 | D016781 | ClinicalTrials |
| Respiratory Distress Syndrome | 1 | D012128 | ClinicalTrials |
| Sepsis | 1 | D018805 | ClinicalTrials |
| Anemia, Sickle Cell | 1 | D000755 | ClinicalTrials |
| Graves Ophthalmopathy | 1 | D049970 | ClinicalTrials |
| Hemorrhagic Fever, Ebola | 1 | D019142 | ClinicalTrials |
| Osteomyelitis | 0 | D010019 | ClinicalTrials |
| Obesity | 0 | D009765 | ClinicalTrials |
Related Entries
MCS
Scaffolds
Side Effects from Label
Side Effects (PT)
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 83905-01-5 |
| ChEBI | 2955 |
| ChEMBL | CHEMBL529 |
| DrugBank | DB00207 |
| DrugCentral | 276 |
| EPA CompTox | DTXSID8030760 |
| FDA SRS | J2KLZ20U1M |
| Human Metabolome Database | HMDB0014352 |
| Guide to Pharmacology | 6510 |
| PDB | ZIT |
| PubChem | 447043 |
| SureChEMBL | SCHEMBL23481 |
| ZINC | ZINC000085537026 |
CONTENTS